Cargando…
A High‐Yielding Synthesis of EIDD‐2801 from Uridine
A simple reordering of the reaction sequence allowed the improved synthesis of EIDD‐2801, an antiviral drug with promising activity against the SARS‐CoV‐2 virus, starting from uridine. Compared to the original route, the yield was enhanced from 17 % to 61 %, and fewer isolation/purification steps we...
Autores principales: | Steiner, Alexander, Znidar, Desiree, Ötvös, Sándor B., Snead, David R., Dallinger, Doris, Kappe, C. Oliver |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894511/ https://www.ncbi.nlm.nih.gov/pubmed/33664631 http://dx.doi.org/10.1002/ejoc.202001340 |
Ejemplares similares
-
Short Synthesis of Molnupiravir (EIDD-2801) via a
Thionated Uridine Intermediate
por: Dey, Raghunath, et al.
Publicado: (2021) -
Progress Toward a Large-Scale Synthesis of Molnupiravir
(MK-4482, EIDD-2801) from Cytidine
por: Ahlqvist, Grace P., et al.
Publicado: (2021) -
SARS-CoV-2 Infection is Effectively Treated and Prevented by EIDD-2801
por: Wahl, Angela, et al.
Publicado: (2021) -
Therapeutic MK-4482/EIDD-2801 Blocks SARS-CoV-2 Transmission in Ferrets
por: Cox, Robert M., et al.
Publicado: (2020) -
Evaluation of molnupiravir (EIDD-2801) efficacy against SARS-CoV-2 in the rhesus macaque model
por: Johnson, Dylan M., et al.
Publicado: (2023)